Correlation research on ADMA plasma levels and left ventricular function of peritoneal dialysis patients

Area of Science:

• Nephrology
• Cardiology
• Biochemistry

Background:

• Cardiovascular disease (CVD) is a major complication in chronic kidney disease (CKD).
• Asymmetric dimethylarginine (ADMA) is implicated in the pathogenesis of CVD in CKD patients.
• Understanding the relationship between ADMA and cardiac function in CKD is crucial.

Purpose of the Study:

• To investigate the association between plasma ADMA levels and echocardiographic parameters.
• To elucidate the relationship between ADMA and left ventricular function in CKD patients.
• To compare ADMA levels and cardiac parameters across different CKD treatment groups.

Main Methods:

• Study included three groups: End-stage renal disease (ESRD) patients on continuous ambulatory peritoneal dialysis (CAPD), conservative treatment for ESRD, and a control group.
• Fasting venous blood samples were collected for ADMA level analysis.
• Echocardiography was performed to assess left ventricular end-diastolic dimension (LVEDD), left atrial diameter (LAD), left ventricular posterior wall thickness (LVPWT), interventricular septum thickness (IVST), and left ventricular ejection fraction (LVEF).

Main Results:

• Significant differences in GFR, urine albumin, SGA, Hb, iPTH, and ALB levels were observed among the three groups.
• Serum ADMA levels differed significantly across the groups (P = 0.000).
• In CAPD patients, plasma ADMA was negatively correlated with LVEF and positively correlated with LVMI, LVM, LVEDD, and LAD. Peritoneal dialysis fluid ADMA positively correlated with LVEF and negatively with LVMI.

Conclusions:

• ADMA levels are significantly different in CKD patients based on treatment modality.
• ADMA is associated with altered left ventricular structure and function, including hypertrophy and reduced ejection fraction.
• ADMA may play a complex role in the cardiac remodeling process in CKD patients.